Relatively recently, it has become apparent that a small but meaningful proportion of schizophrenic patients experience paniclike symptoms as a component of their condition. The full set of ...
Using a multi-strain probiotic formulation, researchers conducted a double-blind, randomized, placebo-controlled trial aimed at improving psychiatric and cognitive symptoms, intestinal permeability, ...
SINGAPORE - A fast, non-invasive form of brain stimulation to reduce persistent negative symptoms such as social withdrawal and lack of motivation in patients with schizophrenia is being tested at ...
Brodmann area 22, namely the superior temporal gyrus, had a greater number of abnormally expressed genes in both diseases; moreover, genes that differentiated AD and schizophrenia patients from ...
Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. | Boehringer Ingelheim’s investigational ...
Boehringer healthcare HCP Illustrative image Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, ...